Maite M. T. van Haeren

Maite M. T. van Haeren

Auto-generated profile, based on publicly available information

Maite M. T. van Haeren

Department of Intensive Care Amsterdam University Medical Centers Amsterdam The Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in British Journal of Anaesthesia
Verified
Journal Article
Open access
MHMaite M.T. van Haeren
Maite M.T. van Haeren
JBJenni S. Breel
Jenni S. Breel
JSJimmy Schenk
Jimmy Schenk
SESusanne Eberl
Susanne Eberl
HHHenrike Hamer
Henrike Hamer
HSHerbert Schoechl
Herbert Schoechl
Thromboelastometry plays a key role in many transfusion algorithms. ROTEM® Sigma is the fully automated successor of ROTEM® Delta. Compatibility with current ROTEM® Delta-based algorithms remains uncertain. This study compares ROTEM® Delta with ROTEM® Sigma in patients undergoing thoracic aortic surgery. Three ROTEM® measurements in duplicate (one Delta and one Sigma) per patient were performed during aortic surgery. The primary outcome was the percentage of patients who would have received a different haemostatic intervention after protamine reversal based on the institutional ROTEM®-guided transfusion algorithm ('deviation'). A 10% deviation was deemed acceptable. Secondary outcomes were differences in numerical values assessed by Passing-Bablok regressions, Bland-Altman plots, and correlations with conventional coagulation tests. Of 111 patients, 102 had matched post-protamine ROTEM® measurements. There were 43 algorithm deviations. Most deviations (29) were attributable to conflicting advice on CT EXTEM-based plasma or prothrombin complex concentrate (PCC) administration; in 25 patients, Delta results advised the administration of plasma or PCC, whereas Sigma did not, and vice versa in four patients. Deviations on additional protamine, fibrinogen concentrate, or platelet administration were acceptable. All numerical ROTEM® variables examined passed the criteria for equivalence, except for A10 FIBTEM at baseline and A10 EXTEM in heparinised and post-protamine samples, which would not have led to clinical consequences. Correlations with conventional coagulation tests were similar or better for Sigma compared with Delta. ROTEM® Sigma can be used with existing ROTEM-guided transfusion algorithms in cardiothoracic surgery except for the advice for administration of plasma or PCC. Netherlands trial register NL8273.

18 December 2024 in Transfusion
Verified
Journal Article
Open access
MHMaite M. T. van Haeren
Maite M. T. van Haeren
SRSenta Jorinde Raasveld
Senta Jorinde Raasveld
SBSanne de Bruin
Sanne de Bruin
MRMerijn Constantijn Reuland
Merijn Constantijn Reuland
COClaudia van Den Oord
Claudia van Den Oord
TGthe InPUT Study Group
the InPUT Study Group
Background: Current guidelines discourage prophylactic plasma use in non‐bleeding patients. This study assesses global plasma transfusion practices in the intensive care unit (ICU) and their alignment with current guidelines.Study Design and Methods: This was a sub‐study of an international, prospective, observational cohort. Primary outcomes were in‐ICU occurrence rate of plasma transfusion, proportion of plasma events of total blood products events, and number of plasma units per event. Secondary outcomes included transfusion indications, INR/PT, and proportion of events for non‐bleeding indications.Results: Of 3643 patients included, 356 patients (10%) experienced 547 plasma transfusion events, accounting for 18% of total transfusion events. A median of 2 (IQR 1, 2) units was given per event excluding massive transfusion protocol (MTP) and 3 (IQR 2, 6) when MTP was activated. MTP accounted for 39 (7%) of events. Indications of non‐MTP events included active bleeding (54%), prophylactic (25%), and pre‐procedure (12%). Target INR/PT was stated for 43% of transfusion events; pre‐transfusion INR/PT or visco‐elastic hemostatic assays (VHA) were reported for 73%. Thirty‐seven percent of events were administered for non‐bleeding indications, 54% with a pre‐transfusion INR < 3.0 and 30% with an INR < 1.5.Discussion: Plasma transfusions occurred in 10% of ICU patients. Over a third were given for non‐bleeding indications and might have been avoidable. Target INR/PT was not stated in more than half of transfusions, and pre‐transfusion INR/PT or VHA was not reported for 27%. Further research and education is needed to optimize guideline implementation and to identify appropriate indications for plasma transfusion.

15 April 2025 in Anaesthesia
Verified
Journal Article
Open access
MHMaite M. T. van Haeren
Maite M. T. van Haeren
MBMeike Brouwers
Meike Brouwers
JSJimmy Schenk
Jimmy Schenk
JBJennifer S. Breel
Jennifer S. Breel
SNSijm H. Noteboom
Sijm H. Noteboom
HHHenning Hermanns
Henning Hermanns
Summary: Introduction: Rotational thromboelastometry (ROTEM ® ) is used widely in cardiac surgery. Reference ranges are derived from healthy volunteers but may not be interchangeable with those from patients undergoing cardiac surgery. Furthermore, sex and age seem to influence rotational thromboelastometry profiles. We performed a secondary analysis of two prospective observational study cohorts from a single centre in the Netherlands, which establishes pre‐operative ROTEM ® sigma reference ranges for adult patients undergoing cardiac surgery and examines sex‐ and age‐specific variations. Methods: Reference ranges (2.5–97.5th percentiles) were compared with those reported by the manufacturer by calculating 95% CIs around the percentiles. Sex‐ and age‐specific variations were evaluated similarly by creating subgroups (comparing males with females and different age groups) and calculating the 95% CIs for the ranges in each subgroup. Non‐overlapping CIs indicated statistically significant different ranges. Results: We included 381 patients in the analysis. Differences were found in ROTEM sigma reference ranges compared with those stated by the manufacturer: EXTEM and FIBTEM clot firmness upper limits were higher, and clotting time ranges in EXTEM and INTEM were wider. The lower limit of LI60 EXTEM was lower. When comparing males (n = 260) and females (n = 121), female patients had shorter CT EXTEM and higher A5, A10 and MCF in EXTEM and FIBTEM, but the reference ranges were not significantly different. No differences in medians or reference bounds were found across four age categories, divided by quartiles. Discussion: Reference ranges for patients undergoing cardiac surgery differed from the manufacturer reference ranges. Pre‐operatively, female patients exhibited a slightly more hypercoagulable ROTEM profile than males when comparing medians, though the reference ranges were similar. No differences were found across age categories. Cardiovascular‐specific, but not sex‐ or age‐specific ROTEM sigma reference ranges might be needed.

22 April 2025 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
MHMaite M.T. van Haeren
Maite M.T. van Haeren
CBCaitlin Bozic
Caitlin Bozic
SESusanne Eberl
Susanne Eberl
MHMarkus W. Hollmann
Markus W. Hollmann
JBJennifer S. Breel
Jennifer S. Breel
HHHenning Hermanns
Henning Hermanns
This study aimed to analyze the impact of aortic valve morphology on preoperative coagulation status in patients undergoing elective thoracic aortic surgery. Preoperative ROTEM and conventional coagulation tests of patients with a bicuspid aortic valve (BAV) were compared to those with a tricuspid aortic valve (TAV). An exploratory prospective observational study. Conducted in a single center. The study included 169 patients (63 BAV and 106 TAV). None. Mann-Whitney U tests were conducted to compare the groups. Regression analysis was performed to evaluate the association between valve morphology and abnormal ROTEM profiles. BAV patients were on average 10 years younger and had a median aortic diameter 5 mm smaller. No significant differences were found in preoperative ROTEM values or coagulation tests between groups, except for higher D-dimers in TAV patients. Sex was a significant confounder, and aortic diameter was a significant mediator. TAV patients required more red blood cell and platelet transfusions, likely due to more preoperative antiplatelet therapy and longer cardiopulmonary bypass times. Mortality and postoperative complications were similar between groups. Patients with a BAV have similar preoperative coagulation profiles and postoperative outcomes as TAV patients, based on ROTEM and conventional coagulation tests. While TAV patients required more RBC and platelet transfusions, this is likely due to factors other than valve type. These findings suggest that BAV patients do not need altered coagulation management despite structural differences and endothelial dysfunction.